Skip to main content
رجوع
ALLO logo

Allogene Therapeutics, Inc.

جودة البيانات: 100%
ALLO
NASDAQ Healthcare Biotechnology
KWD 2.44
▲ KWD 0.37 (17.87%)
القيمة السوقية: 548.34M
نطاق اليوم
KWD 2.13 KWD 2.60
نطاق 52 أسبوعًا
KWD 0.86 KWD 2.80
حجم التداول
11,639,138
متوسط 50 يوم / 200 يوم
KWD 2.01 / KWD 1.45
الإغلاق السابق
KWD 2.07

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -2.9 0.4
P/B 1.9 2.9
ROE % -53.4 3.7
Net Margin % 3.8
Rev Growth 5Y % 10.0
D/E 0.3 0.2

النقاط الرئيسية

Debt/Equity of 0.26 — conservative balance sheet
Negative free cash flow of -149.63M
PEG of 0.05 suggests growth is underpriced

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-53.42%
ROIC-42.22%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.26
Current Ratio7.93
Interest Coverage-192.50

التقييم

P/E Ratio
-2.87
P/B Ratio1.87
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -100.00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -190.89M
ROE -53.42% ROA -45.90%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -149.63M
ROIC -42.22% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.26 Current Ratio 7.93
Interest Coverage -192.50 Dividend Yield 0.00%
Valuation
P/E Ratio -2.87 P/B Ratio 1.87
P/S Ratio N/A PEG Ratio 0.05
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 548.34M Enterprise Value 571.70M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 22,000.0 95,000.0 156,000.0 114.09M
Net Income -190.89M -257.59M -327.27M -340.41M -182.05M
EPS (Diluted) -0.87 -1.32 -2.09 -2.38 -1.34
Gross Profit -12.36M 22,000.0 95,000.0 -14.14M 114.09M
Operating Income -206.93M -273.20M -327.74M -335.54M -180.19M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 415.91M 548.71M 642.84M 821.58M 1.05B
Total Liabilities 123.36M 126.53M 130.60M 154.70M 125.63M
Shareholders' Equity 292.54M 422.18M 512.23M 666.88M 925.20M
Total Debt 75.05M 90.76M 95.12M 101.12M 73.13M
Cash & Equivalents 51.69M 75.22M 83.16M 61.90M 173.31M
Current Assets 257.75M 303.39M 459.12M 528.82M 471.32M
Current Liabilities 32.51M 35.52M 37.08M 53.73M 47.91M